Immune checkpoint inhibitor treatment - real-world use and outcomes in Sweden 2015-2023.

Illergard K, Soto P, Arpegård J, Schiza A, Pahnke S

Open source

DOI
10.48101/ujms.v131.14245
Published
2026
Container
Upsala journal of medical sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.48101/ujms.v131.14245,
  title = {Immune checkpoint inhibitor treatment - real-world use and outcomes in Sweden 2015-2023.},
  author = {Illergard K and Soto P and Arpegård J and Schiza A and Pahnke S},
  year = {2026},
  journal = {Upsala journal of medical sciences},
  doi = {10.48101/ujms.v131.14245},
  url = {https://doi.org/10.48101/ujms.v131.14245}
}

RIS

TY  - JOUR
TI  - Immune checkpoint inhibitor treatment - real-world use and outcomes in Sweden 2015-2023.
AU  - Illergard K
AU  - Soto P
AU  - Arpegård J
AU  - Schiza A
AU  - Pahnke S
PY  - 2026
JO  - Upsala journal of medical sciences
DO  - 10.48101/ujms.v131.14245
UR  - https://doi.org/10.48101/ujms.v131.14245
ER  - 

APA

K, I., P, S., J, A., A, S., & S, P. (2026). Immune checkpoint inhibitor treatment - real-world use and outcomes in Sweden 2015-2023.. Upsala journal of medical sciences. https://doi.org/10.48101/ujms.v131.14245

Source records